ConvaTec to launch repricing of U.S. and euro term loan B on Friday

By Sara Rosenberg

New York, March 3 - ConvaTec Healthcare is scheduled to hold a conference call on Friday to launch a refinancing/repricing of its $500 million term loan B and €550 million term loan B, according to a market source.

J.P. Morgan Securities LLC and Goldman Sachs & Co. are the lead banks on the deal.

Late last year, as part of a refinancing initiative, the company priced the existing term loan B debt at Libor/Euribor plus 425 basis points with a 1.5% Libor floor and sold it at an original issue discount of 991/2.

ConvaTec is a Skillman, N.J.-based developer, manufacturer and marketer of medical technologies for community and hospital care.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.